Muhammed Shiraz Moosa

A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug–Induced Liver Injury

Muhammed Shiraz Moosa, Gary Maartens, Hannah Gunter et al. · Clinical Infectious Diseases · 2020 · 48 citations

Plasma Pharmacokinetics of High-Dose Oral versus Intravenous Rifampicin in Patients with Tuberculous Meningitis: a Randomized Controlled Trial

Sean Wasserman, Angharad Davis, Cari Stek et al. · Antimicrobial Agents and Chemotherapy · 2021 · 37 citations · Full text

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial

Angharad Davis, Sean Wasserman, Cari Stek et al. · Clinical Infectious Diseases · 2022 · 37 citations · Full text

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

Angharad Davis, Sean Wasserman, Mpumi Maxebengula et al. · Wellcome Open Research · 2021 · 12 citations · Full text

Analysis of serum microRNA‐122 in a randomized controlled trial of N‐acetylcysteine for treatment of antituberculosis drug‐induced liver injury

Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R. Dorfman et al. · British Journal of Clinical Pharmacology · 2023 · 11 citations · Full text